Hemostatic effect of a novel sheeted fibrin adhesive agent, TO-193, on experimental incision models
TO-193 (TachoComb®) is a new fibrin adhesive agent that consists of a collagen sheet coated with fibrin glue. We compared the hemostatic effect of TO-193 in several experimental models with Beriplast® P as a fibrin adhesive agent, Avitene® and Novacol® as a microfibrillar collagen hemostat, and a sp...
Gespeichert in:
Veröffentlicht in: | Folia Pharmacologica Japonica 1999, Vol.113(3), pp.177-184 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | jpn |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | TO-193 (TachoComb®) is a new fibrin adhesive agent that consists of a collagen sheet coated with fibrin glue. We compared the hemostatic effect of TO-193 in several experimental models with Beriplast® P as a fibrin adhesive agent, Avitene® and Novacol® as a microfibrillar collagen hemostat, and a sponge-like collagen sheet as the constitutional parts of TO-193. In the in vitro bleeding model in which blood leaks out through cotton cloth, the pressure of TO-193 when blood leakage was observed was higher than those of Beriplast® P, Avitene®, Novacol® and the collagen sheet, indicating that TO-193 possessed a strong adhesive effect on the bleeding surface. On the kidney resection surface, TO-193 showed a more potent adhesive effect than those of Beriplast® P and the collagen sheet, suggesting that TO-193 has a potent hemostatic effect. In the liver resection, TO-193 significantly reduced the bleeding volume compared with that of Novacol® in normal rats. Furthermore, the bleeding volume of TO-193 was about half that of Beriplast® P and equivalent to that of Novacol® even in anticoagulant-treated rats. From these data, it is expected that TO-193 would be a valuable hemostatic agent for clinical use since TO-193 possesses a potent adhesive ability on the bleeding resection surface and would certainly stop bleeding in both patients with normal coagulation and those with a low blood coagulation condition. |
---|---|
ISSN: | 0015-5691 1347-8397 |
DOI: | 10.1254/fpj.113.177 |